Smallwood et al. demonstrated that autologous patient CD4+ T cells internalize chronic lymphocytic leukemia (CLL)-derived small EVs containing miR-363 that targets the immunomodulatory receptor CD69, which leads to inhibit the migration of effector T cells [112,113,114]. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.